Prot# RIVAROXHFA1001 (Impact 12980): A Randomized, Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Rivaroxaban in Subjects with Acute (Open-Label, Active-Controlled) or Chronic (Double-Blind, Placebo-Controlled) Congest

Project: Research project

Project Details

StatusFinished
Effective start/end date4/24/0812/13/08

Funding

  • Janssen Research & Development, LLC (RIVAROXHFA1001 (Impact 12980):)